Cancer incidence after immunosuppressive treatment following kidney transplantation

Critical Reviews in Oncology/Hematology

Volumn 56, Issue 1 SPEC. ISS., 2005, Pages 71-85

  Andrés, Amado ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cancer; Immunosuppression; Kidney transplant; Neoplasm; Post transplant malignancies; Renal transplant; Tumor

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ANTIVIRUS AGENT; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; RAPAMYCIN; RITUXIMAB; TUMOR MARKER;

ANALGESIC NEPHROPATHY; BLADDER CARCINOMA; CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CANCER SUSCEPTIBILITY; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG SAFETY; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPHOMA; MEDULLOBLASTOMA; MELANOMA; METASTASIS; MULTIPLE MYELOMA; ORGAN DONOR; PANCREAS ADENOCARCINOMA; PROGNOSIS; PROSTATE ADENOCARCINOMA; RECURRENCE RISK; REVIEW; RISK FACTOR; SKIN CANCER; STOMACH ADENOCARCINOMA; TESTIS CANCER; THYROID PAPILLARY CARCINOMA; TONGUE CANCER; URINARY TRACT CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; VAGINA CANCER; VIRUS INFECTION; VULVA CANCER;

EID: 24644523670     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2004.11.010     Document Type: Review

References (98)

1. J.F. Mahony, R.J. Caterson, S. Coulshed, J.H. Stewart, and A.G. Sheil Twenty and 25 years survival after cadaveric renal transplantation Transplant Proc 27 1995 2154 2155
2. http://www.ipttr.uc.edu
3. I. Penn Post-transplant malignancy: the role of immunosuppression Drug Saf 23 2000 101 113
4. I. Penn Occurrence of cancers in immunosuppressed organ transplant recipients Clin Transplant 1 1998 147 158
5. I. Penn Posttransplant malignancies Transplant Proc 31 1999 1260 1262
6. S.A. Birkeland, H. Lokkegaard, and H.H. Storm Cancer risk in patients on dialysis and after renal transplantation Lancet 355 2000 1886 1887
7. S.A. Birkeland Effect of two cyclosporin regimens on cancer frequency in kidney-graft recipients Lancet 352 1998 364
8. S.A. Birkeland De novo cancers complicating renal transplantation: experience in the Nordic countries Ann Transplant 2 1997 22 26
9. S.A. Birkeland, H.H. Storm, and L.U. Lamm Cancer risk after renal transplantation in the Nordic countries, 1964-1986 Int J Cancer 60 1995 183 189
10. A.G. Sheil Patterns of malignancies following renal transplantation Transplant Proc 31 1999 1263 1265
11. A.G. Sheil Development of malignancy following renal transplantation in Australia and New Zealand Transplant Proc 24 1992 1275 1279
12. A.G. Sheil, A.P. Disney, T.H. Mathew, B.E. Livingston, and A.M. Keogh Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation Transplant Proc 29 1997 825 827
13. F.P. Brunner, P. Landais, and N.H. Selwood Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association Nephrol Dial Transplant 10 Suppl. 1 1995 74 80
14. P. Maisonneuve, L. Agodoa, and R. Gellert Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Lancet 354 1999 93 99
15. J.H. Stewart, G. Buccianti, and L. Agodoa Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand J Am Soc Nephrol 14 2003 197 207
16. M.S. Dunnill, P.R. Millard, and D. Oliver Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis J Clin Pathol 30 1977 868 877
17. J.C. Herrero, E. Gutierrez, and A. Martinez Results of kidney transplantation in recipients over 70 years of age: experience at a single center Transplant Proc 35 2003 1675 1676
18. I. Penn Evaluation of transplant candidates with pre-existing malignancies Ann Transplant 2 1997 14 17
19. I. Penn The effect of immunosuppression on pre-existing cancers Transplantation 55 1993 742 747
20. EBPG (European Expert Group on Renal Transplantation); European Renal. Association (ERA-EDTA); European Society for Organ Transplantation (ESOT) European Best Practice Guidelines for Renal Transplantation (part 1) Nephrol Dial Transplant 15 2000 1 85
21. B.L. Kasiske, E.L. Ramos, and R.S. Gaston The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians J Am Soc Nephrol 6 1995 1 34
22. J.R. Chapman, A.G. Sheil, and A.P. Disney Recurrence of cancer after renal transplantation Transplant Proc 33 2001 1830 1831
23. V.M. Conraads, J. Denollet, A. Vorlat, A.C. Moulijn, and C.J. Vrints Screening for solid organ malignancies prior to heart transplantation Transplant Proc 71 2001 1481 1483
24. B.L. Kasiske, M.A. Vazquez, and W.E. Harmon Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation J Am Soc Nephrol 11 Suppl. 15 2000 S1 S86
25. B.A. Kiberd, T. Keough-Ryan, and C.M. Clase Screening for prostate, breast and colorectal cancer in renal transplant recipients Am J Transplant 3 2003 619 625
26. I. Penn Transmission of cancer from organ donors Ann Transplant 2 1997 7 12
27. I. Penn Transmission of cancer from organ donors Nefrologia 15 1995 205 213
28. M. Fernandez Lucas, and R. Matesanz Estandarización en los criterios de donación de órganos para prevenir la transmisión de enfermedades neoplásicas Nefrologia 21 2001 91 96
29. International Consensus Document Standardization of Organ Donor Screening to Prevent Transmission of Neoplastic Diseases. Select Committee of Expert in the Organisational Aspects of Cooperation in Organ Transplantation, Council of Europe. Transplant Newslett., 1997;2.
30. B. Pasquier, D. Pasquier, A. N'Golet, M.H. Panh, and P. Couderc Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study of two cases and review of literature Cancer 45 1980 112 125
31. G.M. Kleinman, F.H. Hochberg, and EP. Richardson Jr. Systemic metastases from medulloblastoma: report of two cases and review of the literature Cancer 48 1981 2296 2309
32. N. Lefrancois, J.L. Touraine, and D. Cantarovich Transmission of medulloblastoma from cadaver donor to three organ transplant recipients Transplant Proc 19 1987 2242
33. J.H. Morse, J.G. Turcotte, R.M. Merion, D.A. Campbell Jr., G.D. Burtch, and M.R. Lucey Development of a malignant tumor in a liver transplant graft procured from a donor with a cerebral neoplasm Transplantation 50 1990 875 877
34. J.C. Ruiz, J.G. Cotorruelo, and V. Tudela Transmission of glioblastoma multiforme to two kidney transplant recipients from the same donor in the absence of ventricular shunt Transplantation 55 1993 682 683
35. A. Konigsrainer, W. Steurer, and J. Schumer Transmission of non-Hodgkin's lymphoma through renal allografts - disastrous result of false diagnosis and inadequate information Transplant Proc 25 1993 3075 3076
36. S.D. Colquhoun, M.E. Robert, and A. Shaked Transmission of CNS malignancy by organ transplantation Transplantation 57 1994 970 974
37. S. Jonas, W.O. Bechstein, H.P. Lemmens, R. Neuhaus, U. Thalmann, and P. Neuhaus Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia Transplant Int 9 1996 426 429
38. J.L. Bosmans, D. Ysebaert, and A.M. De Cock Interferon-alpha and the cure of metastasis of a malignant meningioma in a kidney allograft recipient: a case report Transplant Proc 29 1997 838
39. S. Frank, J. Muller, C. Bonk, G. Haroske, H.K. Schackert, and G. Schackert Transmission of glioblastoma multiforme through liver transplantation Lancet 352 9121 July 4, 1998 31 No abstract available. Erratum in: Lancet 1998, 352:316
40. J.F. Buell, J. Trofe, and G. Sethuraman Donors with central nervous system malignancies: are they truly safe? Transplantation 76 2003 340 343
41. H.M. Kauffman, M.A. McBride, W.S. Cherikh, P.C. Spain, and F.L. Delmonico Transplant tumor registry: donors with central nervous system tumors1 Transplantation 73 2002 579 582
42. A.K. Chui, K. Herbertt, and L.S. Wang Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report Transplant Proc 31 1999 1266 1267
43. H.M. Kauffman, M.A. McBride, and F.L. Delmonico First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer Transplantation 70 2000 1747 1751
44. H.M. Kauffman, M.A. McBride, W.S. Cherikh, P.C. Spain, W.H. Marks, and A.M. Roza Transplant tumor registry: donors related malignancies Transplantation 74 2002 358 362
45. E. Fernandez-Zinke, J. Cañón, S. Ramón, M. Crespo, M. Gonzalez, and B. Miranda Trasmisión de enfermedades neoplasicas de donantes de órganos sólidos: la experiencia española 1990-2000 Rev Esp Trasp 9 2000 214 218
46. S.A. Birkeland, and H.H. Storm Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors Transplantation 74 2002 1409 1413
47. A. Andres Donors' selection: organs viability criteria Organ Tissues 3 2001 147 156
48. A. Lopez-Navidad, and F. Caballero Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool Clin Transplant 17 2003 308 324
49. M.A. Frutos, D. Daga, P. Ruiz, J. Jose Mansilla, and M.V. Requena Prostate-specific antigen in the assessment of organ donors Transplant Proc 35 2003 1644 1646
50. E. Loh, F.J. Couch, and C. Hendricksen Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation JAMA 277 1997 133 137
51. E.W. Wafa, A.F. Donia, and B. Ali-El-Dein Evaluation and selection of potential live kidney donors J Urol 171 2004 1424 1427
52. B.L. Kasiske, J.J. Snyder, D.T. Gilbertson, and C. Wang Cancer after kidney transplantation in the United States Am J Transplant 4 6 June 2004 905 913
53. T. Stewart, S.C. Tsai, H. Grayson, R. Henderson, and G. Opelz Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation Lancet 346 1995 796 798
54. A.G. Sheil Cancer in dialysis and transplant patients PJ. Morris Kidney Transplantation. Principles and Practice 2001 Saunders Philadelphia 558 570
55. J. Adami, H. Gabel, and B. Lindelof Cancer risk following organ transplantation: a nationwide cohort study in Sweden Br J Cancer 89 2003 1221 1227
56. I. Lampreabe, J. Amenazar, and F. Garcia Canceres en receptores de trasplante: ensayo de estudio cooperativo español Nefrologia 13 Suppl. 1 1993 85 abstract
57. L. Kyllonen, K. Salmela, and E. Pukkala Cancer incidence in a kidney-transplanted population Transplant Int 13 Suppl. 1 2000 S394 S398
58. J. Vilardell, F. Oppenheimer, and A.M. Castelao Cancer after transplantation in Catalonia Transplant Proc 24 1992 124
59. Y. Hoshida, H. Tsukuma, and Y. Yasunaga Cancer risk after renal transplantation in Japan Int J Cancer 71 1997 517 520
60. C. Hiesse, P. Rieu, and F. Kriaa Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period Transplant Proc 29 1997 831 833
61. J. Mankin, S. Hudson, W.H. Barber, M.H. Deierhoi, and A.G. Diethelm A parametric analysis of the hazard of cancer after transplantation Transplant Proc 21 1989 3201 3204
62. F. Anaya, G. Escribano, and C. Hernandez Incidencia y tratamiento de neoplasias después del trasplante renal Nefrologia 15 1995 42 50
63. E. Danpanich, and B.L. Kasiske Risk factors for cancer in renal transplant recipients Transplantation 68 1999 1859 1864
64. M. Behrend, M. Kolditz, and V. Kliem Malignancies in patients under long-term immunosuppression after kidney transplantation Transplant Proc 29 1997 834 835
65. N. Ishikawa, K. Tanabe, and T. Tokumoto Clinical study of malignancies after renal transplantation and impact of routine screening for early detection: a single-center experience Transplant Proc 32 2000 1907 1910
66. D. Fahlenkamp, P. Reinke, S. Kirchner, D. Schnorr, A. Lindeke, and S.A. Loening Malignant tumours after renal transplantation Scand J Urol Nephrol 30 1996 357 362
67. F. Villacampa, M. Martín, J.M. Duarte, A. Andrés, J.M. Morales, and O. Leiva Incidencia de neoplasias no derivadas de la epidermis en pacientes con trasplante renal Actas Urol Esp 22 Suppl. 5 1998 52 Abstract
68. F. Tremblay, M. Fernandes, F. Habbab, M.D. deB Edwardes, R. Loertscher, and S. Meterissian Mlignancy after renal transplantation: incidence and role of type of immunosuppression Ann Surg Oncol 9 2002 785 788
69. N.J. London, S.M. Farmery, E.J. Will, A.M. Davison, and JP. Lodge Risk of neoplasia in renal transplant patients Lancet 346 1995 403 406 Erratum in: Lancet 1995; 346:714
70. J.C. Pecqueux, A. Schwarz, K.P. Dieckmann, and G. Offermann Cancer incidence in patients on chronic dialysis and in renal transplant recipients Urol Int 45 1990 290 292
71. R. Schmidt, D. Stippel, T. Schmitz-Rixen, and M. Pollok Tumors after renal transplantation Urol Int 57 1996 21 26
72. D. Ondrus, V. Pribylincova, and J. Breza The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy Int Urol Nephrol 31 1999 417 422
73. P. Vogt, U. Frei, H. Repp, H. Bunzendahl, K. Oldhafer, and R. Pichlmayr Malignant tumours in renal transplant recipients receiving cyclosporin: survey of 598 first-kidney transplantations Nephrol Dial Transplant 5 1990 282 288
74. S.B. Gaya, A.J. Rees, R.I. Lechler, G. Williams, and P.D. Mason Malignant disease in patients with long-term renal transplants Transplantation 59 1995 1705 1709
75. J. Dantal, M. Hourmant, and D. Cantarovich Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens Lancet 351 1998 623 628
76. S.A. Slavis, A.C. Novick, and D.R. Steinmuller Outcome of renal transplantation in patients with a functioning graft for 20 years or more J Urol 144 1990 20 22
77. S. Feng, J.F. Buell, R.S. Chari, J.M. DiMaio, and D.W. Hanto Tumors and transplantation: the 2003 Third Annual ASTS State-of-the-Art Winter Symposium Am J Transplant 3 2003 1481 1487
78. J.N. Bouwes Bavinck, D.R. Hardie, and A. Green The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study Transplantation 61 1996 715 721
79. D.W. Hanto Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies Annu Rev Med 46 1995 381 394
80. W.E. Harmon, and V.R. Dharnidharka Lymphoproliferative disease in children Transplant Proc 31 1999 1268 1269
81. R.C. Walker, W.F. Marshall, and J.G. Strickler Pretransplantation assessment of the risk of lymphoproliferative disorder Clin Infect Dis 20 1995 1346 1353
82. S.M. Cockfield, J.K. Preiksaitis, L.D. Jewell, and N.A. Parfrey Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center Transplantation 56 1993 88 96
83. E.M. Sokal, T. Caragiozoglou, M. Lamy, R. Reding, and J.B. Otte Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients Transplantation 56 1993 1394 1398
84. G. Opelz, and R. Henderson Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients Lancet 342 1993 1514 1516
85. G. Opelz, and B. Dohler Lymphomas after solid organ transplantation: a collaborative transplant study report Am J Transplant 4 2004 222 230
86. A.D. Hibberd, P.R. Trevillian, and J.H. Wlodarzcyk Cancer risk associated with ATG/OKT3 in renal transplantation Transplant Proc 31 1999 1271 1272
87. R.T. Bustami, A.O. Ojo, and R.A. Wolfe Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients Am J Transplant 4 2004 87 93
88. L.J. Swinnen, M.R. Costanzo-Nordin, and S.G. Fisher Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients N Engl J Med 323 1990 1723 1728
89. I. Penn Cancers in renal transplant recipients Adv Ren Replace Ther 7 2 2000 147 156
90. C.V. Paya, J.J. Fung, and M.A. Nalesnik Epstein-Barr virus-induced post-transplant lymphoproliferative disorders ASTS/AST EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting Transplantation 68 1999 1517 1525
91. Sayegh MH, Eisen HJ, Brennan DC, Friedberg JP. Lymphoproliferative disorders following solid organ transplantation. In Rose BD ed. UptoDate in Nephrology and Hypertension version 12.2 Renal transplant section www.uptodate.com Wellesley MA, USA 2004.
92. E.S. Woodle, M. Hanaway, and J. Buell Israel Penn International Transplant Tumor Registry. Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry Transplant Proc 33 2001 3660 3661
93. S. Euvrard, J. Kanitakis, and A. Claudy Skin cancers after organ transplantation N Engl J Med 348 2003 1681 1691
94. J.M. Campistol, A. Gutierrez-Dalmau, and J.V. Torregrosa Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma Transplantation 77 2004 760 762
95. I. Penn Primary kidney tumors before and after renal transplantation Transplantation 59 1995 480 485
96. L.B. Jeng, C.C. Huang, M.K. Lai, and S.H. Chu Hepatocellular carcinoma after kidney transplantation Transplant Proc 31 1999 1273 1274
97. F.L. Luan, M. Hojo, M. Maluccio, K. Yamaji, and M. Suthanthiran Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy Transplantation 73 2002 1565 1572
98. F.L. Luan, R. Ding, V.K. Sharma, W.J. Chon, M. Lagman, and M. Suthanthiran Rapamycin is an effective inhibitor of human renal cancer metastasis Kidney Int 63 2003 917 926